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The utilities values were 0.82 with cure and 0.78 with incontinence.
The cure rates with TVT were 0.65 when estimated using actually collected data and 0.68 when adjusted for withdrawals pre-surgery.
Traditional slings would perform the same as open COLP, laparoscopic COLP would perform the same as open COLP or possibly worse, and injectables had poorer cure rates.
The average length of stay was 2.9 days with TVT, 7.1 days with open COLP, 7.2 days with traditional slings, 2 days with injectables, and 4.6 days with laparoscopic COLP.
Theatre time was 30 minutes with TVT, 52.4 minutes with open COLP, 45.6 minutes with traditional slings, and 60 minutes with laparoscopic COLP.
Methods used to derive estimates of effectiveness
The authors made some assumptions to derive model inputs when no published evidence was available.
Estimates of effectiveness and key assumptions
The proportion of women opting for re-treatment after failure of operation was 0.75 for the first re-treatment, 0.30 for the second and 0 for the third. The cure rate of re-treatment open COLP was lower than that of open COLP performed as first-line surgical option.
Measure of benefits used in the economic analysis
The summary benefit measure used was the number of quality-adjusted life-years (QALYs). This was calculated by combining survival and quality-of-life data using the decision model. The utility values were obtained from the literature and based on the EQ-5D. Discounting was carried out at an annual rate of 1.5%.
Direct costs
Discounting was relevant since the costs were incurred during a 10-year timeframe. An annual discount rate of 6% was applied. The economic evaluation comprised all direct medical costs associated with the interventions under evaluation. A detailed breakdown of the cost items was not provided, and the costs were not presented separately from the quantities of resources used. Only the total estimated costs for each procedure were provided. The cost/resource boundary of the NHS was adopted. Resource use was estimated from published estimates. The costs came from manufacturers' prices and NHS reference costs. Some cost estimates were derived from published studies. The price year was 2001.
Statistical analysis of costs
The costs were treated deterministically in the base-case, but triangular probability distributions were assigned to some categories of costs in the probabilistic analysis.
